Key facts
- This page summarizes Stelios Papadopoulos's Form 4 filing for BIOGEN INC. (BIIB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Jun 2022, 17:13.
Stelios Papadopoulos - 15 Jun 2022 Form 4 Insider Report for BIOGEN INC. (BIIB)
- Reporting relationship
- Director
- Issuer ticker
- BIIB
- Reported as of
- 15 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Jun 2022, 17:13:38 UTC
- Prior SEC filing
- 10 Jun 2022
- Next SEC filing
- 14 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Wendell Taylor, Attorney in Fact for Stelios Papadopoulos
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stelios Papadopoulos filed Form 4 for BIOGEN INC. (BIIB) on 17 Jun 2022.
Change
- Previous filing in this sequence was filed on 10 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIIB
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,255
- Change %
- +29%
- Price
- $0.000000
- Shares after
- 10,095
- Date
- 15 Jun 2022
- Ownership
- Direct
BIIB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,831
- Date
- 15 Jun 2022
- Ownership
- Esperanza Holdings, LLC
BIIB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 17,375
- Date
- 15 Jun 2022
- Ownership
- Stelios Holdings, LLC
* marks a reported price that did not pass the local price check.